YISHENG PHARM released its first-quarter performance, with a net profit attributable to the parent company of 11.8616 million yuan, a decrease of 43.56%
YISHENG PHARM released its Q1 2025 performance, with operating revenue of 159 million yuan, a year-on-year decrease of 20.59%; net profit attributable to the parent company of 11.8616 million yuan, a year-on-year decline of 43.56%; net profit excluding non-recurring gains and losses of 8.4386 million yuan, a year-on-year decrease of 53.36%; basic earnings per share of 0.0358 yuan
According to the Zhitong Finance APP, YISHENG PHARM (002566.SZ) released its first quarter report for 2025, with operating revenue of 159 million yuan, a year-on-year decrease of 20.59%. The net profit attributable to shareholders of the listed company was 11.8616 million yuan, a year-on-year decrease of 43.56%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 8.4386 million yuan, a year-on-year decrease of 53.36%. The basic earnings per share were 0.0358 yuan
